Farmako Healthcare

farmako.ai →

-91%

est. 2Y upside i

HealthcareSeed

India's fastest medicine delivery in just 30 minutes

Rank

#2893

Sector

Health Tech

Est. Liquidity

~5Y

Data Quality

Data: Medium

This opportunity offers exposure to an innovative AI-powered quick-commerce pharma model in a large, growing market, but the significant threat from dominant incumbents makes it a high-risk, high-reward proposition for equity.

Last updated: February 16, 2026

Bull (10%)+400%

Farmako successfully differentiates its AI-powered platform, rapidly gains significant market share against incumbents, and achieves a strong acquisition by a major healthcare or tech player.

Base (50%)+50%

The company continues to grow steadily, secures a Series A funding round, but faces ongoing competitive pressure, leading to a modest acquisition or continued private growth.

Bear (40%)-90%

Dominant incumbents stifle growth and market penetration, leading to a distressed sale, inability to raise further capital, or eventual shutdown.

Est. time to liquidity~5.0 years

Community

Valuation Sentiment

Our model estimates -91% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.